Clinical Trial Update: L-5-HTP-Related EMS

View source ↗

Summary

A completed clinical trial update reports safety concerns linking L-5-HTP to eosinophilia-myalgia syndrome (EMS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilia-myalgia Syndrome

Drugs mentioned

• L-5-HTP (5-hydroxytryptophan)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Eosinophilia-Myalgia Syndrome | Status: COMPLETED